Evidence map›Paper›PMID 16601239›Full record

ArticleAmerican journal of respiratory cell and molecular biology2006

PKCalpha mediates CCL18-stimulated collagen production in pulmonary fibroblasts.

Irina G Luzina, Kendrick Highsmith, Kerill Pochetuhen, Natalia Nacu, Jaladanki N Rao, Sergei P Atamas

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. CCL18 in the Progression of Cancer.International journal of molecular sciences · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Interleukin-33 potentiates bleomycin-induced lung injury.American journal of respiratory cell and molecular biology · 2013
    Article
  13. Article
  14. Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2013
    Article
  15. Cytokines in chronic respiratory diseases.F1000 biology reports · 2013
    Article
  16. Article
  17. Article
  18. Article
  19. PKCdelta mediates thrombin-augmented fibroblast-mediated collagen gel contraction.Biochemical and biophysical research communications · 2008
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Irina G LuzinaDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Kendrick Highsmith
Kerill Pochetuhen
Natalia Nacu
Jaladanki N Rao
Sergei P Atamas
University of Maryland, Baltimore · US

Funding

Molecular Mechanism of PARC-Mediated Lung FibrosisR01HL074067 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI ATAMAS, SERGEI P · 2004 to 2007
$928k
NHLBI NIH HHS R01 HL074067
6 · The paper itself

Abstract

A CC chemokine, CCL18, has been previously reported to stimulate collagen production in pulmonary fibroblasts. This study focused on the role of protein kinase C (PKC) in the profibrotic signaling activated by CCL18 in pulmonary fibroblasts. Of the three PKC isoforms that are predominantly expressed in fibroblasts (PKCalpha, PKCdelta, and PKCepsilon), two isoforms (PKCdelta and PKCepsilon) have been implicated in profibrotic intracellular signaling. The role of PKCalpha-mediated signaling in the regulation of collagen production remains unclear. In this study, PKCalpha was found mostly in the cytoplasm, whereas PKCdelta and PKCepsilon were found mostly in the nucleus of cultured primary pulmonary fibroblasts. In response to stimulation with CCL18, PKCalpha but not PKCdelta or PKCepsilon underwent rapid (within 5-10 min) transient phosphorylation and nuclear translocation. Inhibition with dominant-negative mutants of PKCalpha and ERK2, but not PKCdelta or PKCepsilon, abrogated CCL18-stimulated ERK2 phosphorylation and collagen production. The effect of CCL18 on collagen production and the activity of collagen promoter reporter constructs were also abrogated by a selective pharmacologic inhibitor of PKCalpha Gö6976. Stimulation of fibroblasts with CCL18 caused an increase in intracellular calcium concentration. Consistent with the known calcium dependence of PKCalpha signaling, blocking of the calcium signaling with the intracellular calcium-chelating agent BAPTA led to abrogation of PKCalpha nuclear translocation, ERK2 phosphorylation, and collagen production. These observations suggest that in primary pulmonary fibroblasts, PKCalpha but not PKCdelta or PKCepsilon mediate the profibrotic effect of CCL18. PKCalpha may therefore become a viable target for future antifibrotic therapies.

Indexed as

Active Transport, Cell NucleusCalciumCarbazolesCell NucleusCells, CulturedChemokines, CCCollagenCollagen Type ICytoplasmFibroblastsHumansIndolesLungPhosphorylationPromoter Regions, GeneticProtein Kinase C-alphaCalciumCarbazolesCCL18 protein, humanChemokines, CCCollagenCollagen Type IGo 6976IndolesProtein Kinase C-alphaProtein Kinase C-deltaProtein Kinase C-epsilonProtein Kinase Inhibitors

Identifiers

PMID16601239
PMCPMC2643282
OpenAlexW2045912042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.